Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
Authors
Keywords
-
Journal
Lancet Respiratory Medicine
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-04-10
DOI
10.1016/s2213-2600(21)00160-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19
- (2021) Robert L. Gottlieb et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Could new COVID variants undermine vaccines? Labs scramble to find out
- (2021) Ewen Callaway NATURE
- Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
- (2021) Chloe I Bloom et al. Lancet Respiratory Medicine
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 Related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids
- (2020) Michael C Peters et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
- (2020) Stephen A. Lauer et al. ANNALS OF INTERNAL MEDICINE
- COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments
- (2020) Enrico Heffler et al. ALLERGY
- Validation of SARS-CoV-2 detection across multiple specimen types
- (2020) Garrett A. Perchetti et al. JOURNAL OF CLINICAL VIROLOGY
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?
- (2020) Dan V Nicolau et al. Lancet Respiratory Medicine
- Asthma-associated risk for COVID-19 development
- (2020) Chrysanthi Skevaki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells
- (2020) Shutoku Matsuyama et al. JOURNAL OF VIROLOGY
- Inhaled Corticosteroids and COVID-19 Risk and Mortality: A Nationwide Cohort Study
- (2020) Jae Chol Choi et al. Journal of Clinical Medicine
- Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial
- (2020) Fatemeh Roozbeh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
- (2020) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characteristics and outcomes of COVID-19 patients in New York City’s public hospital system
- (2020) Roopa Kalyanaraman Marcello et al. PLoS One
- Antiviral and anti-inflammatory activity of budesonide against human rhinovirus infection mediated via autophagy activation
- (2018) Seong-Ryeol Kim et al. ANTIVIRAL RESEARCH
- Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI)
- (2018) John H. Powers et al. PLoS One
- Stopping guidelines for an effectiveness trial: what should the protocol specify?
- (2016) Jon E. Tyson et al. Trials
- Intensive Care Unit Capacity in Low-Income Countries: A Systematic Review
- (2015) Srinivas Murthy et al. PLoS One
- Effect of different asthma treatments on risk of cold-related exacerbations
- (2011) H. K. Reddel et al. EUROPEAN RESPIRATORY JOURNAL
- Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)
- (2010) J. S. Nguyen-Van-Tam et al. THORAX
- Validity of the Common Cold Questionnaire (CCQ) in Asthma Exacerbations
- (2008) Heather Powell et al. PLoS One
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started